SHMLF (SHL Telemedicine) ROC %: -5.66% (As of Dec. 2025)


SHMLF SHL Telemedicine Ltd SHMLF
51 GF Score
Price $4.84
GF Value $13.95
! 3 Warning Signs
View Full Analysis

What is SHL Telemedicine ROC %?

SHL Telemedicine SHMLF 51 ROC % is -5.66% as of Dec. 2025. GuruFocus rates SHMLF with a GF Score™ of 51/100 and a GF Value™ of $13.95. The stock has 3 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. SHL Telemedicine's annualized return on capital (ROC %) for the quarter that ended in Dec. 2025 was -5.66%.

As of today (2026-06-24), SHL Telemedicine's WACC % is 11.20%. SHL Telemedicine's ROC % is -6.11% (calculated using TTM income statement data). SHL Telemedicine earns returns that do not match up to its cost of capital. It will destroy value as it grows.


SHL Telemedicine  (OTCPK:SHMLF) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, SHL Telemedicine's WACC % is 11.20%. SHL Telemedicine's ROC % is -6.11% (calculated using TTM income statement data). SHL Telemedicine earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


SHL Telemedicine ROC % Related Terms


SHL Telemedicine ROC % Historical Data

* Premium members only.

The historical data trend for SHL Telemedicine's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SHL Telemedicine ROC % Chart

SHL Telemedicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 -0.91 -8.45 -9.27 -6.22

SHL Telemedicine Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.41 -9.21 -9.56 -7.10 -5.66
SHMLF
51GF Score
SHL Telemedicine Ltd SHMLF
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SHL Telemedicine ROC % Calculation

SHL Telemedicine's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=-4.511 * ( 1 - 0% )/( (74.578 + 70.436)/ 2 )
=-4.511/72.507
=-6.22 %

where

SHL Telemedicine's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-3.938 * ( 1 - 0% )/( (68.636 + 70.436)/ 2 )
=-3.938/69.536
=-5.66 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -5.66% mean?
SHL Telemedicine (SHMLF) has a ROC % of -5.66% as of Dec. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on SHL Telemedicine and its competitors.
Is SHL Telemedicine's ROC % too high?
SHL Telemedicine's current ROC % is -5.66%. Overall, SHL Telemedicine has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's ROC % compare to VEEV and BTSG?
SHL Telemedicine's ROC % of -5.66% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROC % is 3.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Healthcare Providers & Services company?
The median ROC % among Healthcare Providers & Services companies is 3.06, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median ROC % is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current ROC % is -5.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current ROC % of -5.66%. The stock's GF Value™ is $13.95, compared to a current price of $4.84 — trading 65.3% below its estimated fair value. The current ROC % is -5.66%. SHL Telemedicine's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current ROC % is -5.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SHL Telemedicine (SHMLF) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of $4.84 is trading 65.3% below its estimated GF Value™ of $13.95.

Key valuation signals for SHMLF:

  • ROC %: -5.66%
  • GF Value™: $13.95 vs. price of $4.84 (65.3% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SHL Telemedicine Business Description

Other Exchanges 0QMX:UKSHLTN:Switzerland
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
51GF Score

Get the complete analysis for SHMLF

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.84
Price
$13.95
GF Value